Smith & Nephew PLC (NYSE:SNN)

35.75
Delayed Data
As of May 23
 -0.07 / -0.20%
Today’s Change
33.72
Today|||52-Week Range
40.43
+2.11%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$15.7B

Company Description

Smith & Nephew Plc engages in the development, manufacture, marketing, and sale of medical devices. It offers the following products and services: sports medicine joint repair; arthroscopic enabling technologies; trauma and extremities; other surgical businesses; knee and hip implants, and advanced wound care, wound bioactives, and wound devices. It operates through the United Kingdom, United States of America, and Other geographical segments. The company was founded by Thomas James Smith in 1856 and is headquartered in London, the United Kingdom.

Contact Information

Smith & Nephew Plc
15 Adam Street
London London & South East WC2N 6LA
P:442074017646
Investor Relations:

Employees

Shareholders

Other institutional7.24%
Mutual fund holders1.24%
Individual stakeholders--

Top Executives

Namal NawanaChief Executive Officer & Executive Director
Matthew R. StoberPresident-Global Operations
Graham BakerChief Financial Officer & Director
Vasant PadmanabhanPresident-Research & Development
Arjun RajaratnamChief Compliance Officer